Filter by year
-
march312020
Newron AGM Result and Clinical and Business Update
-
march112020
Newron updates on STARS study FDA interaction
-
march52020
Newron announces 2019 financial results and provides outlook for 2020
-
february172020
Newron Expands Global Rett Syndrome Burden of Illness Survey Outreach to Europe and Australia
-
february42020
Newron Pharmaceuticals to Present at the 22nd Annual BIO CEO & Investor Conference in New York
-
january92020
Newron announces initiation of new clinical trial with Evenamide in patients with schizophrenia, following approval of plan by FDA